Whether the mitochondrial permeability transition pore (PTP), also called mitochondrial megachannel (MMC), originates from the F-ATP synthase is a matter of controversy. This hypothesis is supported both by site-directed mutagenesis of specific residues of F-ATP synthase affecting regulation of the PTP/MMC and by deletion of specific subunits causing dramatic changes in channel conductance. In contrast, human cells lacking an assembled F-ATP synthase apparently display persistence of the PTP. We discuss recent data that shed new light on this controversy, supporting the conclusion that the PTP/MMC originates from a Ca -dependent conformational change in F-ATP synthase allowing its reversible transformation into a high-conductance channel.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/1873-3468.13485 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
F-ATP Synthase Inhibitors and Targets.
Antibiotics (Basel)
December 2024
School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.
() infection causes tuberculosis (TB). TB is one of the most intractable infectious diseases, causing over 1.13 million deaths annually.
View Article and Find Full Text PDFN-terminal cleavage of cyclophilin D boosts its ability to bind F-ATP synthase.
Commun Biol
November 2024
Department of Medicine, University of Udine, 33100, Udine, Italy.
Cyclophilin (CyP) D is a regulator of the mitochondrial F-ATP synthase. Here we report the discovery of a form of CyPD lacking the first 10 (mouse) or 13 (human) N-terminal residues (ΔN-CyPD), a protein region with species-specific features. NMR studies on recombinant human full-length CyPD (FL-CyPD) and ΔN-CyPD form revealed that the N-terminus is highly flexible, in contrast with the rigid globular part.
View Article and Find Full Text PDFSQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase.
J Antimicrob Chemother
January 2025
School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Republic of Singapore.
Background: Non-tuberculous mycobacteria (NTM) infection presents a growing global health problem and requires new antibiotics targeting enzymes that are essential for the pathogens under various metabolic conditions, with high target specificity, good solubility and with attractive combinatory potency.
Methods: SQ31f was synthesized by a simplified synthesis protocol, and its effect on growth inhibition of fast- and slow-growing NTM and clinical isolates, whole-cell ATP depletion, ex vivo macrophages and its potency in combination with other antibiotics were evaluated. Molecular docking studies were employed to assess SQ31f's binding mode.
Advances in antibacterial agents for .
RSC Med Chem
October 2024
Department of Pharmacy, Health Sciences Centre, Federal University of Santa Maria Santa Maria RS Brazil +55 (55) 3220 9372.
Article Synopsis
- The text discusses the rise of an emerging human pathogen, a type of nontuberculous mycobacterium (NTM), which has shown increased prevalence and antibiotic resistance, emphasizing the need for new drug development.
- It summarizes research over the past 20 years on various compounds that have antimycobacterial properties, focusing on promising synthetic drugs like macozinone and natural products like clostrubin and sansanmycin analogs.
- The review highlights specific mechanisms of action for some compounds, such as NITD-916 and TBAJ-5307, and explores the pathogenic mechanisms and potential therapeutic targets within this NTM.
TBAJ-587, a novel diarylquinoline, is active against .
Antimicrob Agents Chemother
December 2024
Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Nontuberculous mycobacteria (NTM) infections are extremely difficult to treat due to a natural resistance to many antimicrobials. TBAJ-587 is a novel diarylquinoline, which shows higher anti-tuberculosis activity, lower lipophilicity, and weaker inhibition of hERG channels than bedaquiline (BDQ). The susceptibilities of 11 NTM reference strains and 194 clinical isolates to TBAJ-587 were determined by the broth microdilution assay.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!